News from REMEDY

The research seminar opened with center manager Espen A. Haavardsholm presenting the rich annual report for REMEDY 2023. Achievements of young researchers and development in the individual projects, as well as public communication, financial cooperation, etc., were mentioned with pride. A readable PDF of the annual report for 2023 can be found HERE.

REMEDY marked its second year in 2023. The research centre's overall aim is to improve treatments for those living with rheumatological and musculoskeletal diseases. Here you can read about some of what happened in 2023!

A closing meeting for the BRIDGE study was held on 4 March at Gardermoen. Professor Ingvild Kjeken has been the project manager for the study, which has taken place at eight rehabilitation centers in the specialist health service in Norway, and a total of 374 patients have participated.

Research from the REMEDY center at Diakonhjemmet hospital gives hope for a more predictable everyday life for patients with chronic inflammatory disease.

Innovation in patient care is at the center of the feasibility study in the ReMonit Gout project. The study will test the applicability of the patient app, Urika, designed to support people who are about to start uric acid-lowering treatment.

The clinic for rheumatology, outpatient clinic and research has had its status renewed as an EULAR Center of Excellence. The clinic received this status in 2008 and has had it ever since. The status is granted for five years at a time, based on scientific activity in the previous 5 years.

Valeria Melokhina gave a presentation in "Contact meeting for doctors" at Diakonhjemmet hospital on 2 February. - Due to the fact that the war in Ukraine has been going on for 10 years, Valeria held a speech on what her hometown was like before the Russian invasion in 2014 and how the events developed there at that time, said meeting chair, Guro Løvik Goal.

In the ExeHeart study at Diakonhjemmet hospital, researchers have discovered that high-intensity interval training (HIIT) can have significant benefits for patients with joint disease. This is confirmed by Marie Dahlskjær (29), who developed childhood arthritis as a 12-year-old.

Doctor and PhD scholar Marthe Gløersen contributes with her doctorate to a breakthrough in the understanding of pain in hand osteoarthritis. Her research at Diakonhjemmet hospital reveals new insights into the connection between body mass index (BMI), pain sensitization and hand osteoarthritis.